160 related articles for article (PubMed ID: 23261042)
1. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
[TBL] [Abstract][Full Text] [Related]
2. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
[TBL] [Abstract][Full Text] [Related]
3. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.
Tongo M; Zembe L; Ebong E; Roux S; Bekker LG; Williamson C; Mpoudi-Ngole E; Burgers WA
Vaccine; 2014 Apr; 32(20):2328-36. PubMed ID: 24598726
[TBL] [Abstract][Full Text] [Related]
4. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
6. Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.
Serwanga J; Mugaba S; Pimego E; Nanteza B; Lyagoba F; Nakubulwa S; Heath L; Nsubuga RN; Ndembi N; Gotch F; Kaleebu P
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):384-92. PubMed ID: 21867408
[TBL] [Abstract][Full Text] [Related]
7. Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.
Bansal A; Gough E; Ritter D; Wilson C; Mulenga J; Allen S; Goepfert PA
AIDS; 2006 Feb; 20(3):353-60. PubMed ID: 16439868
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of gag-specific IFN-gamma secretion responses in HIV-1 B/C recombinant infectors].
Liu HW; Hong KX; Yuan Y; Liu CH; Chen JP; Ruan YH; Wang Z; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):358-60. PubMed ID: 22338224
[TBL] [Abstract][Full Text] [Related]
10. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
11. Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.
Jiang F; Han X; Zhang H; Zhao B; An M; Xu J; Chu Z; Dong T; Shang H
BMC Immunol; 2016 Aug; 17(1):28. PubMed ID: 27577610
[TBL] [Abstract][Full Text] [Related]
12. Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.
Mugaba S; Nakiboneka R; Nanyonjo M; Bugembe-Lule D; Kaddu I; Nanteza B; Tweyongyere R; Kaleebu P; Serwanga J
Vaccine; 2014 Jun; 32(30):3787-95. PubMed ID: 24837770
[TBL] [Abstract][Full Text] [Related]
13. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
[TBL] [Abstract][Full Text] [Related]
14. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
Coplan PM; Gupta SB; Dubey SA; Pitisuttithum P; Nikas A; Mbewe B; Vardas E; Schechter M; Kallas EG; Freed DC; Fu TM; Mast CT; Puthavathana P; Kublin J; Brown Collins K; Chisi J; Pendame R; Thaler SJ; Gray G; Mcintyre J; Straus WL; Condra JH; Mehrotra DV; Guess HA; Emini EA; Shiver JW
J Infect Dis; 2005 May; 191(9):1427-34. PubMed ID: 15809900
[TBL] [Abstract][Full Text] [Related]
16. Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity.
Frahm N; Nickle DC; Linde CH; Cohen DE; Zuñiga R; Lucchetti A; Roach T; Walker BD; Allen TM; Korber BT; Mullins JI; Brander C
AIDS; 2008 Feb; 22(4):447-56. PubMed ID: 18301057
[TBL] [Abstract][Full Text] [Related]
17. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
[TBL] [Abstract][Full Text] [Related]
18. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.
Malhotra U; Li F; Nolin J; Allison M; Zhao H; Mullins JI; Self S; McElrath MJ
J Virol; 2007 May; 81(10):5225-37. PubMed ID: 17329342
[TBL] [Abstract][Full Text] [Related]
19. Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.
Rolland M; Frahm N; Nickle DC; Jojic N; Deng W; Allen TM; Brander C; Heckerman DE; Mullins JI
PLoS One; 2011 Mar; 6(3):e17969. PubMed ID: 21464919
[TBL] [Abstract][Full Text] [Related]
20. Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.
Tongo M; Riou C; Crunchant E; Müller TL; Strickland N; Mpoudi-Ngole E; Burgers WA
AIDS; 2015 Mar; 29(5):635-639. PubMed ID: 25715106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
